Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Veradermics, Incorporated stake
total: 670
Viking Global Investors MANE trades
- Total transactions:
- 2
- New positions:
- 1
- Reduced:
- 1
- Held since:
- 2026 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Ole Andreas Halvorsen holds 1,561,494 Veradermics, Incorporated (MANE) shares with a market value of roughly $191.97M accounting for 0.55% of the overall portfolio. To date, the estimated cost basis is nearly $63.15 for "buy" trades and estimated average "sell" price is $122.94. Viking Global Investors first purchased MANE in 2026 Q1, initially acquiring about 1.69M shares. Since the initial investment in Veradermics, Incorporated (MANE), Viking Global Investors has made 1 more transaction.
When did Ole Andreas Halvorsen buy Veradermics, Incorporated (MANE)?
Ole Andreas Halvorsen first invested in Veradermics, Incorporated (MANE) in 2026 Q1 at the reported quarter-end price of $63.15 per share.
What's the cost basis of Viking Global Investors's MANE stake?
The estimated cost basis for Veradermics, Incorporated (MANE) stake is around $63.15 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $63.15
- Weighted AVG sell price:
- $122.94
Ole Andreas Halvorsen's historical trades in Veradermics, Incorporated
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.55%
|
1,561,494
|
$122.94
|
$191,970,072
|
-7.63% (-129,061)
|
-0.04%
|
|
2026 Q1
|
0.30%
|
1,690,555
|
$63.15
|
$106,758,548
|
new
|
+0.3%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.